Selective inhibitors of monoamine oxidase .4. SAR of tricyclic N-methylcarboxamides and congeners binding at the tricyclics' hydrophilic binding site

被引:21
作者
Harfenist, M
Joseph, DM
Spence, SC
Mcgee, DPC
Reeves, MD
White, HL
机构
[1] WELLCOME RES LABS,DEPT ORGAN CHEM,RES TRIANGLE PK,NC 27709
[2] WELLCOME RES LABS,DEPT PHARMACOL,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1021/jm9608063
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Linear [6.6.6] tricyclic moieties whose center ring is made of two atoms of differing size (here primarily thioxanth-9-ones and phenoxathiins) monosubstituted meta to the sulfur by C(O)NHMe include potent and selective inhibitors of monoamine oxidase A. Similarities with effects on SAR of acylamide and of diazapentacyclic substitution on such rings, including positional variables, the requirement for monomethylation (primary and dialkylated amides are inactive and higher monoalkylated amides show little or no potency), and that sulfur is optimally in sulfone form, suggest that binding to the enzyme occurs similarly in each series. No significantly greater rise in blood pressure was found in rats given sufficient 8 to inhibit most brain and liver MAO A and then followed by oral tyramine than was found on administration of tyramine to controls. This is in contrast to a large blood pressure rise in rats pretreated with phenelzine followed by tyramine, and in accord with the belief that an inhibitor selective for MAO A which is reversibly bound to the enzyme and therefore displaced by any ingested tyramine will not lead to the ''cheese effect'' (hypertension during treatment with MAO inhibitors usually caused by ingestion of foods containing tyramine).
引用
收藏
页码:2466 / 2473
页数:8
相关论文
共 14 条
[1]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[2]  
Cesura A M, 1992, Prog Drug Res, V38, P171
[3]   SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE .2. ARYLAMIDE SAR [J].
HARFENIST, M ;
JOYNER, CT ;
MIZE, D ;
WHITE, HL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (13) :2085-2089
[4]   Selective inhibitors of monoamine oxidase .3. Structure-activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups [J].
Harfenist, M ;
Heuser, DJ ;
Joyner, CT ;
Batchelor, JF ;
White, HL .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) :1857-1863
[6]  
HARFENIST M, 1988, Patent No. 4737514
[7]   SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].
JOHNSTON, JP .
BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&
[8]  
Marley E, 1970, Adv Pharmacol Chemother, V8, P185
[9]  
MURPHY DL, 1981, MONOAMINE OXIDASE IN, P189
[10]   ADDITIONAL EVIDENCE FOR EXISTENCE OF SEVERAL FORMS OF MITOCHONDRIAL MONOAMINE OXIDASE IN MOUSE [J].
SQUIRES, RF .
BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1401-&